Sahin, A. B. Et Al. 2022. Chemotherapy plus radiotherapy vs. radiotherapy alone in high-risk endometrioid endometrial carcinoma. European Review for Medical and Pharmacological Sciences , vol.26, no.23 , 8959-8968.

Sahin, A. B., Ocak, B., Abakay, C., Çubukçu, E., Deligönül, A., Caner, B., ... Dakiki, B.(2022). Chemotherapy plus radiotherapy vs. radiotherapy alone in high-risk endometrioid endometrial carcinoma. European Review for Medical and Pharmacological Sciences , vol.26, no.23, 8959-8968.

Sahin, AHMET Et Al. "Chemotherapy plus radiotherapy vs. radiotherapy alone in high-risk endometrioid endometrial carcinoma," European Review for Medical and Pharmacological Sciences , vol.26, no.23, 8959-8968, 2022

Sahin, AHMET B. Et Al. "Chemotherapy plus radiotherapy vs. radiotherapy alone in high-risk endometrioid endometrial carcinoma." European Review for Medical and Pharmacological Sciences , vol.26, no.23, pp.8959-8968, 2022

Sahin, A. B. Et Al. (2022) . "Chemotherapy plus radiotherapy vs. radiotherapy alone in high-risk endometrioid endometrial carcinoma." European Review for Medical and Pharmacological Sciences , vol.26, no.23, pp.8959-8968.

@article{article, author={AHMET BİLGEHAN ŞAHİN Et Al. }, title={Chemotherapy plus radiotherapy vs. radiotherapy alone in high-risk endometrioid endometrial carcinoma}, journal={European Review for Medical and Pharmacological Sciences}, year=2022, pages={8959-8968} }